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Impairment of muscle energy metabolism has been demonstrated in normal subjects with chronic 
hypoxaemia (altitude chronic respiratory failure). The purpose of this study was to verify the hypothesis 
that a comparable condition could develop in patients with sleep apnoea syndrome (SAS), considering 
that they are exposed to prolonged and repeated hypoxaemia periods. Muscle metabolism was assessed 
in 11 patients with SAS performing a maximal effort on cycloergometer. In comparison with normal 
subjects, SAS patients reached lower maximal loads [144 f 7 vs. 182 f 10 W (P<O.OOS)] and lower peak 
oxygen uptakes [26.4 f 1.2 vs. 33.2 & 1.4 ml kg- ’ min - ’ (P<O.OOS)]. Abnormal metabolic features 
were found: maximal blood lactate concentration was significantly lower than in normal subjects 
[0.034 f 0.004 vs. 0.044 f 0.002 mmol 1 - ’ W - ’ (P<O.OS)]; and lactate elimination rate, calculated 
during a 30-min recovery period, was reduced [0.127 f 0.017 vs. 0.175 & 0.014 mmol l- ’ min- ’ 
(P<O.O25)]. The extent of these anomalies correlated with the severity of SAS. The patients also showed 
higher maximal diastolic blood pressures than normal subjects [104 + 5 vs. 92 f 4 mmHg (P<O.OS)]. 
These results can be interpreted as indications of an impairment of muscle energy metabolism in 
patients with SAS. Decrease in maximum blood lactate concentration suggests an impairment of 
glycolytic metabolism, while decrease in the rate of lactate elimination indicates a defect in oxidative 
metabolism. Since no respiratory pathology apart from SAS was found in this group of patients, it seems 
legitimate to link the genesis of these impairments to repeated bouts of nocturnal hypoxaemia. 
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Introduction 
Studies by Cerretelli (1) have shown that, whereas the 
decrease in maximum oxygen uptake observed in 
subjects submitted to acute hypoxia is solely due to 
the reduction of oxygen availability, subjects with 
chronic hypoxaemia due to long-lasting exposure to 
high altitude develop impairments of both aerobic 
and anaerobic metabolisms. These findings corrob- 
orated earlier works (24) conducted in patients 
with chronic respiratory insufficiency. It is accepted 
that, in sleep apnoea syndrome (SAS), repetition of 
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nocturnal desaturation episodes results in a state 
equivalent to chronic hypoxaemia (5). 
The aim of this study was to evaluate tolerance 
of exercise in subjects with SAS confirmed by poly- 
somnographic recordings. The starting hypothesis 
was that these patients could present the same del- 
eterious effects of hypoxaemia as those with chronic 
hypoxaemia of other origins. 
Materials and Methods 
PATIENTS 
Eleven patients with obstructive SAS confirmed by 
polysomnographic recordings were selected for this 
study. Physical characteristics, apnoea index and 
minimal nocturnal oxygen saturation (SaO,) are 
presented in Table 1. 
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TABLE 1. Physical characteristics of normal subjects 
and sleep apnoea syndrome (SAS) patients, with 
apnoea index and nocturnal minimal arterial satura- 
tion (SaO, mini) 
Body SaO, 
Age Height Weight mass Apnoea mini 
(years) (cm) (kg) index index v4 
Normal subjects 
41.9 174.7 
3.1 2.8 
Patients 
47.8 174.9 
4.1 2.5 
80.0 26.4 
2.9 1.2 
81.3 26.6 25.6 85.4 
2.7 1 4.5 1.5 
NS NS NS NS 
Mean values f standard error. NS, not significant. 
Selection criteria of patients excluded all other 
causes of low O2 delivery, such as anaemia, conges- 
tive heart failure and haemoglobinopathy. The 
control group consisted of nine normal sedentary 
subjects, free from any cardiac and respiratory dis- 
ease and matched for age, height, weight and body 
mass index for the group of patients. Body mass 
index (BMI) was used as an index of obesity; it was 
calculated by dividing a subject’s weight in kilograms 
by the square of his height in metres. Sleep studies 
were not performed in control subjects, but none 
of these subjects were thought to have any cardio- 
respiratory disease; their clinical examination and 
chest X-ray were normal, and none of them presented 
nocturnal snoring with daytime somnolence. How- 
ever, these signs motivated medical advice and 
polysomnographic recordings in the SAS group. Con- 
trol subjects and patients were either non-smokers 
or occasional smokers; none of these were under 
treatment for any disease, and all had a sedentary 
profession and did not practise any sporting activity. 
Sleep sfudies 
All patients underwent overnight sleep studies in a 
sleep laboratory, between 10 p.m. and 6 a.m. Naso- 
buccal airflow was recorded by a thermistance; tidal 
volume and movements of the rib cage and abdomen 
were quantified by means of respiratory induc- 
tive plethysmography. Arterial 0, saturation was 
measured by cutaneous oxymetry (DATEX). Apnoea 
was considered to be absence of the thermistance 
signal for at least 10 s. Obstructive apnoea was 
diagnosed by the presence of an apnoeic episode 
despite persistent thoraco-abdominal movements. 
Nocturnal polygraphic recordings confirmed SAS 
based on mean apnoea index (number of apnoeas per 
hour) greater than 10. Minimal nocturnal oxygen 
saturation was the arithmetic mean of minimum 
SaO, recorded during each episode of apnoea. 
Both patients and control subjects had given their 
informed consent to the protocol, that had been 
previously approved by the local Ethical Committee. 
RESPIRATORY FUNCTION TESTS 
Pulmonary function testing (Jaeger Masterlab, 
Wurzburg, Germany) included assessment of the 
following parameters: vital capacity (VC), forced 
expiratory volume in 1 s (FEV,), FEV,NC ratio and 
maximal ventilatory volume per minute (MVV). 
Arterial blood gases (PaO,, PaCO,) and plasmatic 
pH were evaluated in duplicate from 150 ~1 blood 
samples taken at the ear lobe. The ear lobe capillary 
blood was arterialized by the application of a 
FINALGON pommade (Boehringer-Ingelheim, 
Germany) for 20 min. The ear lobe was incised with 
a blood lance& long point (Becton Dickinson, 
Meylan, France). Arterialized samples were collected 
in heparinized glass capillaries (Instrumentation 
Laboratory, Milan, Italy) and immediately intro- 
duced into the blood gas analyser (BG Electrolytes, 
Instrumentation Laboratory). 
Haemoglobin concentration (Hb) and carbon 
monoxide haemoglobin saturation (HbCO) were 
measured with an oximeter (OSM2 Radiometer); 
HbCO was determined after chemical reduction of 
the blood samples. 
PROTOCOL 
Exercise was performed on a cycloergometer (ER 900 
Jaeger). Testing sessions took place 2-3 h after break- 
fast. Room ambient temperature ranged from 22 to 
24°C. After a 2-min warm-up period, load was 
increased by 20 W every 2 min up to exhaustion or 
until the subject presented two of the accepted criteria 
of maximal exertion: reaching maximal heart rate as 
given by Astrand’s formula (220-age in years) (6); a 
respiratory ratio exceeding 1.05; or lack of a further 
increase in oxygen uptake although minute respirat- 
ory flow kept increasing. If these conditions were not 
fulfilled at the time of exhaustion, the oxygen uptake 
reached at the end of the last load level was called 
‘peak oxygen uptake’. The following parameters were 
automatically calculated for each minute of effort, 
although only the values measured at the second 
minute of each load level have been retained for this 
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TABLE 2. Spirometric values, arterial blood gases (PaO, and PaCO, mmHg), haemoglobin 
concentration (Hb) and carboxyhaemoglobin saturation (HbCO) of normal subjects and 
patients at rest 
FVC FEV, FEV,/FVC 
Blood gas 
HbCO 
(1) (1) (%) PaO, PaCO, PHa (g?) (W 
Normal subjects 
5.26 4.05 
0.31 0.18 
Patients 
4.94 3.76 
0.26 0.21 
76.7 83.5 40.1 7.408 15.2 1.7 
2.3 2.3 0.9 0.005 0.4 0.4 
75.8 82.9 39.2 7.411 14.9 1.8 
1.8 2.0 0.8 0.006 0.2 0.3 
NS NS NS NS NS NS NS NS 
Mean values & standard error. NS, not significant. 
Normal subjects Patients 
FIG. 1. Maximum load (mean values f I SE) in 
normal subjects (182 f 10 W) and patients 
(144 f 7 W). “P<O.O05. 
study: oxygen uptake (VO, STPD 1 min - ’ and 
ml min - ’ kg - ‘), respiratory ratio (RR= VCO,/ 
VO,), respiratory frequency (RF), tidal volume (K), 
minute expiratory volume (VE BTPS 1 min - I), oxy- 
gen pulse (VOJHR). Heart rate (HR) was calculated 
from standard electrocardiogram derivations during 
exercise and recovery periods. Systemic arterial blood 
pressure (ABP) was measured at the end of each load 
level. Maximum minute expiratory volume ( VE max) 
was measured at maximal load level. Ventilatory 
reserve was calculated as the ratio (MVV-Vnmax)/ 
MVV. Estimation of ventilatory threshold (VT) for 
each subject was accomplished by plotting minute 
ventilation ( VE BTPS) as a function of exercise inten- 
sity (in watts) to ascertain a break in linearity. All 
threshold determinations were performed indepen- 
dently by two investigators. VT was expressed as a 
percentage of maximal load (7). 
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FIG. 2. Heart rate (HR mean values f 1 SE) vs. 
oxygen uptake (%VO, max) in normal subjects (0) 
and patients (0). R, rest; WU, warm up. “PcO.02. 
Arterial blood samples were taken at rest, at maxi- 
mal load and 5, 10 and 30 min after the end of exercise 
(R5, RlO, R30). The following measurements were 
performed: blood gases (BG Electrolytes, Instru- 
mentation Laboratory); blood lactate (Boehringer 
micromethod) and ammonia (Ammonia checker 
4120, Menarini, France). Lactate elimination rate 
during the recovery period was calculated as the slope 
of regression line (lact) vs. time (min); maximum 
lactate concentration measured at the end of exercise 
and the three lactate concentrations measured during 
recovery were used for calculations. 
Statistical analysis 
Mean values of parameters are given with f 1 stan- 
dard error (SE). Intergroup comparisons were 
performed with an unpaired t-test. Changes in PaO, 
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TABLE 3. Values of cardiovascular parameters at rest and at maximal exercise load 
Arterial blood pressure 
HR 
(b min - ‘) 
Systolic Diastolic 
0, pulse 
Rest Max Rest Max (ml beat - ‘) 
Normal subjects 
166 (92.8) 
8 (2.6) 
Patients 
160 (93.3) 
5 (2.4) 
132 194 83 92 15.6 
3 6 3 4 0.6 
143 206 99 104 13.6 
4 7 4 5 0.7 
NS PCO.05 NS P<O.O05 PCO.05 NS 
Values in parentheses represent the percentage of maximum heart rate (220-age in years) 
reached by the subjects. Mean values & standard error. 
HR, maximum heart rate; NS, not significant. 
TABLE 4. Values of respiratory parameters at maximal exercise load 
Peak VO, 
(mlmin-‘kg-‘) RR max 
VE max VR V. thres. 
(1 min - r BTPS) (%I (%I 
Normal subjects 
33.2 
1.4 
Patients 
26.4 
1.2 
1.05 80.1 45.2 72.3 
0.01 3.1 3.5 3.1 
1.02 68.1 49.1 57.8 
0.04 6.1 3.8 2.4 
P<O.O05 NS NS NS P<O.O05 
Peak VO,, VO, measured at maximal load; RR max, respiratory ratio; VE max, maximal 
minute ventilation; VR, ventilatory reserve (see text); V.thresh., ventilatory threshold. 
Mean values + standard error. NS, not significant. 
between rest and maximum load level were evaluated 
with a paired t-test. Correlations between parameters 
were assessed by least square regression analysis. 
Significant differences were established at a PcO.05 
level. 
Results 
At rest, ventilatory parameters, arterial blood, 
haemoglobin concentration and carbon monoxide 
haemoglobin saturation did not differ significantly 
between the patient group and the control group 
(Table 2). 
Mean maximum load sustained by the patients was 
significantly lower than in the control subjects [144 vs. 
182 W (P~O.005, Fig. l)]. All subjects nearly per- 
formed maximal efforts; maximal heart rates of 166 
and 160 reached by the patients and the control 
subjects, respectively, did not differ and corresponded 
to 93% of the theoretical maximal values (Table 3). 
All patients were forced to stop the effort by exhaus- 
tion, associated with myalgia in eight patients. 
Cardiovascular parameters measured during exercise 
testing are presented in Table 3. Heart rate increase as 
a function of VO, did not differ between the patients 
and the control subjects (Fig. 2). Resting systolic and 
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diastolic ABP were significantly higher in the 
patients. Maximal systolic ABP were comparable in 
the two groups, whereas maximal diastolic ABP was 
significantly higher in the patients (P<O.O5). Oxygen 
pulses were similar in the two groups. Survey of 
respiratory parameters (Table 4) showed a significant 
lower peak V02 in the patients than in the control 
subjects [26.4 vs. 33.2 ml min- ’ kg- ’ (P<O.OOS)]. No 
significant differences appeared between VE max, 
maximum RR and ventilatory reserves in the two 
groups. Ventilatory thresholds were situated respect- 
ively at 57.8 f 2.4% and 72.3 f 3.1% of maximal load 
in the patients and in the control group (P<O.O05). 
PaO, measured at the end of exercise (PaO, max) 
were significantly higher than at rest in both groups 
(P<O.O05). PaO, max was higher in the patients than 
in the control subjects (P<O.Ol). Evolutions of PaCO, 
and pH were similar in the two groups (Fig. 3). 
Metabolic data are presented in Table 5. At rest, 
blood lactate and ammonia concentrations were 
similar in the two groups. Maximal blood lactate 
concentrations, expressed in mmol 1 - ’ W - ’ were 
significantly lower in the patients (PcO.05). Lactate 
elimination rate during recovery was slower in the 
patients than in the control subjects (PcO.025). Both 
groups presented similar maximal ammonaemia. 
Correlations are presented in Table 6. 
Discussion 
These results show a decrease in aerobic capacity in 
the patients with SAS. Severity of SAS seems to be 
directly implicated in the genesis of this impair- 
ment, since the decrease of peak VO, was propor- 
tional to the number of apnoeas and to the degree of 
desaturation reached. 
Ability to perform exercise depends on inter- 
relations between muscle energy metabolism, cardiac 
output and ventilatory function (8). Thus, perform- 
ance limitation may result from one or several of 
these factors. In normal subjects, limitation is 
principally related to cardiac function (9). 
A ventilatory limitation can be ruled out immedi- 
ately in the subjects with SAS. In these patients, 
arterial oxygen partial pressure increased at the end 
of exercise as it did in the control subjects (P<O.O05), 
while ventilatory reserve (49%) was greater than the 
theoretical inferior limit of 30% proposed by Patessio 
(10). Three facts make a limitation of cardiac origin 
unlikely: a similar increase in heart rate with oxygen 
uptake in both groups, the absence of hypoxaemia 
and a normal value of oxygen pulse constitute 
arguments in support of a normal increase of cardiac 
output during exercise (8,ll). The abnormal increase 
in diastolic blood pressure in SAS patients gives 
(a) 
80 I I 
Rest 100% 
41, T 1 
4Ot 
36 t 
I 
35 (b) I I 
Rest 100% 
x,7.36 1 
7.34 F 
7.32 
t (4 7.30 
1 
Rest 100% 
FIG. 3. Evolution between resting level and maxi- 
mal load of: (a) arterial oxygen partial pressure 
(PaO,), (b) arterial carbon dioxide partial pressure 
(PaO,); and (c) arterial blood pH. -, normal 
subjects; - - -, patients. Mean values f 1 SE. 
“P<O.Ol. 
evidence of an increase in peripheral resistance to 
blood flow. The resulting decrease in muscle blood 
supply may explain the early onset of ventilatory 
threshold, but does not account for the decrease in 
maximal oxygen uptake (8). 
An impairment of muscle energy metabolism 
stands as the most probable limiting factor. Exhaus- 
tion in all patients with onset of myalgia in eight 
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TABLE 5. Blood concentrations of lactate and ammonia 
Blood lactate Ammonia 
Rest Max Max El. rate Rest Max Max 
(mmoll-‘) (mmoll-‘) (mmoll-‘W-l) (mmolll’min-‘) @mall-‘) @mall-‘) ($moll-‘W-l) 
Normal subjects 
0.74 7.91 0.044 0.175 35.8 91.9 0.51 
0.04 0.49 0.002 0.014 2.9 8.9 0.04 
Patients 
0.63 4.87 0.034 0.126 30.6 70.9 0.52 
0.07 0.52 0.004 0.017 2.6 13.7 0.11 
NS P<O.O05 P<Oh05 P<O,O25 NS NS NS 
NS, not significant. 
El. rate, lactate elimination rate during recovery (see text), as slope of regression line between[lact]mmol 1 - ’ and 
time (min); r 2 0.990. 
TABLE 6. Correlations between various parameters 
concerning (a) adaptation to exercise and sleep study 
data; and (b) increases in arterial blood pressure 
(ABP) and NH, maximum levels during exercise 
Y X r P< 
(a) Exercise vs. sleep studies 
VO, peak Apnoea index - 0.687 
SaO, mini 0.654 
HR max Apnoea index - 0.567 
El. rate Apnoea index - 0.652 
SaO, mini 0.679 
Lact. peak Apnoea index - 0.584 
SaO, mini 0.544 
(b) Increases in ABP and NH, max 
Normal subjects 
A P. syst. NH, max 0*288 
d P. diast. NH, max 0.882 
Patients 
A P. syst. NH, max 0.529 
A P. diast. NH, max 0.720 
NS, not significant. 
0.05 
0.05 
NS 
0.05 
0.05 
0.05 
NS 
NS 
0.002 
NS 
0.01 
subjects brought about stopping the exercise test. 
Two metabolic impairments were observed: on the 
one hand, the significantly lowered maximal blood 
lactate concentration found in patients suggests a 
decrease in glycolytic metabolism; on the other hand, 
the decrease in the lactate elimination rate observed 
during recovery indicates an impairment of oxidative 
metabolism, since lactate elimination depends mainly 
on oxidative metabolic pathways (12-14). The 
decrease in oxidative metabolism can be due to a 
decrease in the number of type I fibres (2) and/or to 
decreases in the volume of mitochondria and in the 
activity of oxidative enzymes, as has been shown in 
altitude chronic hypoxia (1). Episodes of apnoea 
appear to be involved since lactate elimination rate is 
related to apnoea index and to nocturnal desatu- 
ration. Total duration of the periods of nocturnal 
hypoxaemia in SAS patients averaged 70 min, and the 
levels of desaturation reached in these periods were 
similar to those observed during exposure to an 
altitude of 4500 m (15); Cerretelli’s studies were con- 
ducted at comparable altitudes (1). Two mechanisms 
can account for the decrease in glycolytic metabolism: 
an inhibition of glycolytic enzymes and/or a decrease 
in the intramyocytic glycogen store. Nocturnal 
hypoxaemia is accompanied with hypercapnia and 
acidosis (11). Among various effects, acidosis inhibits 
phospho-fructokinase (PFK), a key enzyme to glyco- 
lytic pathway, and lactate dehydrogenase (LDH). 
This effect is due to the fact that both PFK and 
LDH have an elevated optimum action pH (1,16). In 
addition, hypoxaemia, eventually aggravated by a 
decrease in cardiac output (17), brings on a state of 
stress with an increased secretion of catecholamines 
(18). Now epinephrine inhibits glycogen synthetase 
which is the main enzyme of glycogen synthesis (19). 
Therefore, this chain of events leads to a decrease in 
the intramyocytic glycogen store, as it occurs in 
patients with hypoxaemia respiratory insufficiency (2) 
or simply after a common surgical operation (20). 
Hypoxic exposure is shorter in SAS patients than 
in subjects living at high altitude, or in chronic 
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respiratory insufficiency. However, repeated hypox- 
aemic episodes in SAS may impair muscle metab- 
olism through a cumulative effect. A similar effect has 
been referred to by Maillard et al. to explain changes 
in erythrocyte metabolism observed in SAS (21). 
Furthermore, it has been demonstrated that poly- 
cythemia and nocturnal hypoxaemia are inter-related 
(22,23) and that intermittent hypoxaemic episodes 
represent a more intense stimulus of erythrocytic 
production than chronic hypoxaemia (24). 
Sleep deprivation may alter diurnal alertness 
and physical fitness of SAS patients (25). However, 
there is no available information about metabolic 
components of these clinical observations. 
The correlation between blood ammonia concen- 
tration and diastolic arterial blood pressure found in 
the patients and in the control subjects agree with the 
findings of Lewis (26); an intravenous injection of 
ammonium chloride in the hind-limb of a cat induces 
a vasopressor reflex, the mechanisms of which have 
not yet been confirmed. 
Conclusion 
This study showed an impairment of aerobic and 
anaerobic metabolism in patients with SAS. The 
exercise limitation seems to be essentially linked to 
muscular factors. The respective parts played by the 
length of evolution, the extent of symptoms and 
the impact of treatment deserve more extensive 
studies. 
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